ARK Kraaifontein PMTCT trial

Trial Profile

ARK Kraaifontein PMTCT trial

Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Lamivudine/zidovudine (Primary) ; Lopinavir/ritonavir (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms ARKKFTN
  • Most Recent Events

    • 30 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top